HONLIV HEALTH9906.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, HONLIV HEALTH (9906.HK) trades at a P/E of 86.00x, P/B of N/A, P/S of 1.24x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 94th percentile over the trailing 10Y window (vs. 87th percentile over 3Y); P/B historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/S sits at the 23rd percentile over the trailing 10Y window (vs. 42nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 90th percentile within its industry and the 94th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. HONLIV HEALTH operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 9906 · SEHK: 9906 · 9906
Want the full picture on whether HONLIV HEALTH (9906.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 86.00 | ||||||
| P/B (MRQ) | N/A | — | — | — | — | — | — |
| P/S (TTM) | 1.24 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |